New York City, NY -- (SBWIRE) -- 01/02/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts.
Grab your cell phone and text the word "PICKS" to "555888”. StockMarketIntel.com issues a special report on the following stocks: Patient Safety Technologies Inc (OTCMKTS:PSTX), Zurich Insurance Group Ltd (ADR) (OTCMKTS:ZURVY), Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT), Deutsche Telekom AG (ADR) (OTCMKTS:DTEGY)
Patient Safety Technologies Inc (OTCMKTS:PSTX) recently, while trading on 496,067 shares at the price of $2.20. If we look at its trading history of the past 52 weeks, the share price suffered a low of $1.10 and was moved to its maximum level of $2.36.The stock changed hands in a range of $2.20 to $2.21, bringing its market capitalization at about $86.48 million. Patient Safety Technologies, Inc. (Patient Safety) focuses on the development, marketing and sale of products designed to improve patient outcomes and reduce costs in the healthcare industry. The Company conducts its business through its wholly owned subsidiary, SurgiCount Medical, Inc. (SurgiCount).
Can Investors Bet on PSTX after this News update? Find out in this Research Report
Zurich Insurance Group Ltd (ADR) (OTCMKTS:ZURVY) declined -2.23% recently, in the current trading session, at $28.52 with a total volume of 58,866 shares. The stock, on average, trades on a volume of 87,903 shares. In the past 52 weeks, the share price has not declined below $24.20 and above $29.26.It floated in a range of $28.40 to $28.80 during the recent trading session, with a beta value of 1.38.Its market capitalization now moved to about $42.08 billion. Zurich Insurance Group Limited is a Switzerland-based holding company engaged in the insurance sector. The Company provides a range of general and life insurance products and services for individuals, small business, mid-sized and large-sized companies, and multinational corporations.
Has ZURVY Found The Bottom and Ready To Move Up? Find Out Here
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) recently recorded a gain of 3.73% and was moving within a range of $2.46-$2.54. Its current trading price is $2.50. The share price hit its 52-week low of $0.55 and $2.59 was the best price. The stock completed the day with a total volume of 621,711 shares, versus an average volume of 1.49 million shares. Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications. The Company develops and focuses to license or market and sells its two prescription drug candidates, PV-10 and PH-10.
What was the Moving Force behind PVCT on Bullish Run? Read This Research Report
Deutsche Telekom AG (ADR) (OTCMKTS:DTEGY) declined -3.88% in its current trading activity, bringing its market capitalization around $73.81 billion. The total number of shares that changed hands during the current session up till now was 236,786 shares, as compared to average trading volume of 420,761 shares. The share price after opening at $16.69 made a high of $16.69 and hovered above $16.52, while its recent trading price was $16.58. Deutsche Telekom AG is a Germany-based integrated telecommunications provider offering its customers a portfolio of services in the areas of telecommunications and information technology (IT).
Has DTEGY Found The Bottom And Ready To Gain Momentum? Find Out Here
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts.
Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)